Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/21/2003CA2049733C 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, a process for their preparation and their use as medicaments
10/21/2003CA2037100C 6-substituted-hexahydrobenz ¢cd! indoles
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085137A1 Antisense modulation of liver glycogen phosphorylase expression
10/16/2003WO2003085127A2 Method for identification of insulin receptor kinase activators
10/16/2003WO2003085125A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/16/2003WO2003085110A2 Oligomeric compounds for the modulation hif-1alpha expression
10/16/2003WO2003085106A1 Preventives and/or remedies for cancer
10/16/2003WO2003085090A2 A human ribonucleotide reductase m2 subunit
10/16/2003WO2003084978A1 Steroidal quinols as prodrugs of antioxidants
10/16/2003WO2003084975A1 New analogs of nitrobenzylthioinosine
10/16/2003WO2003084966A1 Oxazolidinone derivatives
10/16/2003WO2003084964A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003WO2003084963A1 Non-steroidal progesterone receptor modulators
10/16/2003WO2003084962A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084953A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003WO2003084952A1 Benzoxazinone-derived compounds, their preparation und use as medicaments
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084950A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
10/16/2003WO2003084949A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084945A1 An antispastic, analgetic pharmaceutical composition and the preparation method thereof as well as the quality control technique therefor
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084939A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084934A1 Novel crystal form of 5-hydroxy-1-methylhydantoin
10/16/2003WO2003084932A1 Method for preparing 6-aminomethyl-6,11-dihydro-5h-dibenz[b,e]azepine
10/16/2003WO2003084929A1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
10/16/2003WO2003084928A1 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084926A2 Polymeric acyl derivatives of indoles
10/16/2003WO2003084922A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084610A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
10/16/2003WO2003084609A1 Preparation for treating climacteric post-menopausal complaints, containing a dehydroepiandrosterone and an estradiol
10/16/2003WO2003084582A1 Embolization
10/16/2003WO2003084572A1 Medicinal composition comprising acat inhibitor and insuline resistance improving agent
10/16/2003WO2003084571A1 Therapeutic composition for bone infectious disease
10/16/2003WO2003084560A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003WO2003084558A1 Improved kavalactone profile
10/16/2003WO2003084557A1 Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family
10/16/2003WO2003084553A1 Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis
10/16/2003WO2003084551A1 Agents for treating flaviviridae infections
10/16/2003WO2003084550A1 Drugs for the arthritis treatment
10/16/2003WO2003084549A1 Hormone replacement therapy
10/16/2003WO2003084548A1 SOFT GELATINE CAPSULE CONTAINING A 17α ESTRADIOL AND ASCORBIC ACID
10/16/2003WO2003084547A1 Step-down estrogen therapy
10/16/2003WO2003084546A1 Method of hormonal therapy
10/16/2003WO2003084545A1 Drug containing riboflavin compound
10/16/2003WO2003084544A2 Compounds dor increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis
10/16/2003WO2003084543A1 Combination of glivec(sti571) with a cyclin-dependent kinase inhibitor, especially flavopiridol in the treatment of cancer
10/16/2003WO2003084542A1 Neurotrophic factor production accelerator
10/16/2003WO2003084541A1 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
10/16/2003WO2003084540A2 Compositions comprising mmp7 modulators for the treatment of chronic pain
10/16/2003WO2003084539A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003WO2003084538A1 Methods for treating rosacea with pyridones
10/16/2003WO2003084537A1 Therapeutic agent for food competence disorder in stomach
10/16/2003WO2003084536A1 Oral administration of epothilones
10/16/2003WO2003084535A1 Antidiabetic agents
10/16/2003WO2003084534A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
10/16/2003WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003WO2003084531A1 Vitamin combination for providing protection during the chemotherapy and/or radiotherapy of malignant tumours
10/16/2003WO2003084530A1 Novel therapeutical use of byakangelicin
10/16/2003WO2003084529A2 Low-pressure mercury vapor discharge lamp
10/16/2003WO2003084528A1 A method for reversing permeability modifications caused by acute peritonitis
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084526A1 Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia
10/16/2003WO2003084525A1 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
10/16/2003WO2003084524A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003WO2003084523A1 Use of a n,n'-dibenzyl-thiourea as medicine
10/16/2003WO2003084522A1 Novel therapeutical use of erythro-1 (4'-methoxyphenyl)1,2-propanediol
10/16/2003WO2003084521A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003WO2003084520A2 Pharmaceutical preparation containing oxycodone and naloxone
10/16/2003WO2003084519A2 Aerosol formulation for inhalation comprising a tiotropium salt
10/16/2003WO2003084518A2 Oral suspension of active principle microcapsules
10/16/2003WO2003084517A2 Oral suspension of amoxicillin capsules
10/16/2003WO2003084515A1 Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
10/16/2003WO2003084514A1 Controlled release pharmaceutical compositions of carbidopa and levodopa
10/16/2003WO2003084513A1 Controlled release solid dosage carbamazepine formulations
10/16/2003WO2003084512A1 Oral delivery of a botanical
10/16/2003WO2003084511A1 Palatable chewable tablet
10/16/2003WO2003084510A1 Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions
10/16/2003WO2003084509A1 Powder formulations suitable for inhalation
10/16/2003WO2003084506A1 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
10/16/2003WO2003084504A2 Matrix for sustained, invariant and independent release of active compounds
10/16/2003WO2003084503A2 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003WO2003084502A1 Inhalation kit comprisung inhalable powder of tiotropium
10/16/2003WO2003084499A2 Gel cleaning preparations comprising pre-gelatinised, cross-linked starch derivatives and polyacrylates
10/16/2003WO2003084486A1 Cosmetic and dermatological washing active preparations containing one or more pregelatinized, cross-linked starch derivatives and one or more ethoxylated oils
1 ... 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 5319 5320 5321 5322 5323 5324 5325 5326 ... 7860